|
1
|
Nadeem A, Mumtaz S, Naveed AK, Aslam M,
Siddiqui A and Lodhi GM: Pattern of dyslipidaemia and impact of
increasing age and duration of type 2 diabetes mellitus on
dyslipidaemia, insulin levels and insulin resistance. J Pak Med
Assoc. 65:928–932. 2015.PubMed/NCBI
|
|
2
|
Tomkin GH and Owens D: Dyslipidaemia of
diabetes and the intestine. World J Diabetes. 6:970–977. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hermans MP and Valensi P: Elevated
triglycerides and low high-density lipoprotein cholesterol level as
marker of very high risk in type 2 diabetes. Curr Opin Endocrinol
Diabetes Obes. 25:118–129. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wong ND, Zhao Y, Patel R, Patao C, Malik
S, Bertoni AG, Correa A, Folsom AR, Kachroo S, Mukherjee J, et al:
cardiovascular risk factor targets and cardiovascular disease event
risk in diabetes: A pooling project of the atherosclerosis risk in
communities study, multi-ethnic study of atherosclerosis, and
Jackson heart study. Diabetes Care. 39:668–676. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sylvetsky AC, Edelstein SL, Walford G,
Boyko EJ, Horton ES, Ibebuogu UN, Knowler WC, Montez MG, Temprosa
M, Hoskin M, et al: A high-carbohydrate, high-fiber, low-fat diet
results in weight loss among adults at high risk of type 2
diabetes. J Nutr. 147:2060–2066. 2017.PubMed/NCBI
|
|
6
|
van Goor H, van den Born JC, Hillebrands
JL and Joles JA: Hydrogen sulfide in hypertension. Curr Opin
Nephrol Hypertens. 25:107–113. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Xu Y, Dai X, Zhu D, Xu X, Gao C and Wu C:
An exogenous hydrogen sulphide donor, NaHS, inhibits the apoptosis
signaling pathway to exert cardio-protective effects in a rat
hemorrhagic shock model. Int J Clin Exp Pathol. 8:6245–6254.
2015.PubMed/NCBI
|
|
8
|
Nagpure BV and Bian JS: Brain, learning,
and memory: Role of H2S in neurodegenerative diseases. Handb Exp
Pharmacol. 230:193–215. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Guo SB, Duan ZJ, Wang QM, Zhou Q, Li Q and
Sun XY: Endogenous carbon monoxide downregulates hepatic
cystathionine-γ-lyase in rats with liver cirrhosis. Exp Ther Med.
10:2039–2046. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Aboubakr EM, Taye A, El-Moselhy MA and
Hassan MK: Protective effect of hydrogen sulfide against cold
restraint stress-induced gastric mucosal injury in rats. Arch Pharm
Res. 36:1507–1515. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Jin S, Pu SX, Hou CL, Ma FF, Li N, Li XH,
Tan B, Tao BB, Wang MJ and Zhu YC: Cardiac H2S generation is
reduced in ageing diabetic mice. Oxid Med Cell Longev.
2015:7583582015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Brancaleone V, Roviezzo F, Vellecco V, De
Gruttola L, Bucci M and Cirino G: Biosynthesis of H2S is impaired
in non-obese diabetic (NOD) mice. Br J Pharmacol. 155:673–680.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wu D, Zheng N, Qi K, Cheng H, Sun Z, Gao
B, Zhang Y, Pang W, Huangfu C, Ji S, et al: Exogenous hydrogen
sulfide mitigates the fatty liver in obese mice through improving
lipid metabolism and antioxidant potential. Med Gas Res. 5:12015.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Suzuki K, Sagara M, Aoki C, Tanaka S and
Aso Y: Clinical implication of plasma hydrogen sulfide levels in
Japanese patients with type 2 diabetes. Intern Med. 56:17–21. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Carter RN and Morton NM: Cysteine and
hydrogen sulphide in the regulation of metabolism: Insights from
genetics and pharmacology. J Pathol. 238:321–332. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Steinberg GR and Schertzer JD: AMPK
promotes macrophage fatty acid oxidative metabolism to mitigate
inflammation: Implications for diabetes and cardiovascular disease.
Immunol Cell Biol. 92:340–345. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
O'Neill HM, Holloway GP and Steinberg GR:
AMPK regulation of fatty acid metabolism and mitochondrial
biogenesis: Implications for obesity. Mol Cell Endocrinol.
366:135–151. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Coughlan KA, Valentine RJ, Ruderman NB and
Saha AK: AMPK activation: A therapeutic target for type 2 diabetes?
Diabetes Metab Syndr Obes. 7:241–253. 2014.PubMed/NCBI
|
|
19
|
Lu S, Guan Q, Liu Y, Wang H, Xu W, Li X,
Fu Y, Gao L, Zhao J and Wang X: Role of extrathyroidal TSHR
expression in adipocyte differentiation and its association with
obesity. Lipids Health Dis. 11:172012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Howell G III and Mangum L: Exposure to
bioaccumulative organochlorine compounds alters adipogenesis, fatty
acid uptake, and adipokine production in NIH3T3-L1 cells. Toxicol
In Vitro. 25:394–402. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Li L, Bhatia M, Zhu YZ, Zhu YC, Ramnath
RD, Wang ZJ, Anuar FB, Whiteman M, Salto-Tellez M and Moore PK:
Hydrogen sulfide is a novel mediator of lipopolysaccharide-induced
inflammation in the mouse. FASEB J. 19:1196–1198. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Pan Z, Wang H, Liu Y, Yu C, Zhang Y, Chen
J, Wang X and Guan Q: Involvement of CSE/H2S in high glucose
induced aberrant secretion of adipokines in 3T3-L1 adipocytes.
Lipids Health Dis. 13:1552014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hardie DG: The AMP-activated protein
kinase pathway-new players upstream and downstream. J Cell Sci.
117:5479–5487. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Saha AK and Ruderman NB: Malonyl-CoA and
AMP-activated protein kinase: An expanding partnership. Mol Cell
Biochem. 253:65–70. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Halse R, Fryer LG, McCormack JG, Carling D
and Yeaman SJ: Regulation of glycogen synthase by glucose and
glycogen: A possible role for AMP-activated protein kinase.
Diabetes. 52:9–15. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Foretz M, Ancellin N, Andreelli F,
Saintillan Y, Grondin P, Kahn A, Thorens B, Vaulont S and Viollet
B: Short-term overexpression of a constitutively active form of
AMP-activated protein kinase in the liver leads to mild
hypoglycemia and fatty liver. Diabetes. 54:1331–1339. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Sabater AG, Ribot J, Priego T, Vazquez I,
Frank S, Palou A and Buchwald-Werner S: Consumption of a mango
fruit powder protects mice from high-fat induced insulin resistance
and hepatic fat accumulation. Cell Physiol Biochem. 42:564–578.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Andreelli F, Foretz M, Knauf C, Cani PD,
Perrin C, Iglesias MA, Pillot B, Bado A, Tronche F, Mithieux G, et
al: Liver adenosine monophosphate-activated kinase-alpha2 catalytic
subunit is a key target for the control of hepatic glucose
production by adiponectin and leptin but not insulin.
Endocrinology. 147:2432–2441. 2006. View Article : Google Scholar : PubMed/NCBI
|
